The oocyte capacity to rejuvenate a differentiated nucleus to restart the proper embryonic program has been highly conserved between vertebrate species. In view of the recent progress to induce pluripotency in somatic cells with stemness genes, we investigated the potential of oocyte genes to contribute to chromatin rearrangements in somatic cells. We selected conserved genes that are naturally expressed mainly in oocytes and that were susceptible to play a role in reprogramming during early embryogenesis. We induced their expression by transient transfection in HEK293 cells. We then assessed whether they had a global impact on epigenetic events such as histone core modifications, and also on transcription and expression of pluripotency-associated transcription factors. Nucleoplasmin 2 (NPM2), activation-induced cytidine deaminase (AICDA), and Geminin (GMNN) overexpression induced differences in histone core modifications (methylation and acetylation). AICDA and NPM2 also influenced RNA neosynthesis. NPM2, GMNN, and STELLA induced overexpression of well-known pluripotency transcription factors. Overall, AICDA, GMNN, NPM2, and STELLA influenced at least one of the aspects analyzed. Their potential could be useful in increasing the cell receptivity to pluripotency induction.
Get full access to this article
View all access options for this article.
References
1.
AoiT., YaeK.et al.2008. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science, 321:699–702.
2.
BernalJ.A., LunaR.et al.2002. Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis. Nat. Genet., 32:306–311.
3.
BetthauserJ.M., Pfister-GenskowM.et al.2006. Nucleoplasmin facilitates reprogramming and in vivo development of bovine nuclear transfer embryos. Mol. Reprod. Dev., 73:977–986.
4.
BortvinA., EgganK.et al.2003. Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. Development, 130:1673–1680.
5.
BowlesJ., TeasdaleRPet al.2003. Dppa3 is a marker of pluripotency and has a human homologue that is expressed in germ cell tumours. Cytogenet. Genome Res., 101:261–265.
6.
BurnsK.H., ViveirosM.M.et al.2003. Roles of NPM2 in chromatin and nucleolar organization in oocytes and embryos. Science, 300:633–636.
7.
DerryM.C., YanagiyaA.et al.2006. Regulation of poly(A)-binding protein through PABP-interacting proteins. Cold Spring Harb. Symp. Quant. Biol., 71:537–543.
8.
GaliovaG., BartovaE.et al.2008. Chromatin changes induced by lamin A/C deficiency and the histone deacetylase inhibitor trichostatin A. Eur J. Cell Biol., 87:291–303.
9.
GonzalezM.A., TachibanaK.E.et al.2006. Geminin is essential to prevent endoreduplication and to form pluripotent cells during mammalian development. Genes Dev., 20:1880–1884.
10.
HamidT., MalikM.T.et al.2005. Ectopic expression of PTTG1/securin promotes tumorigenesis in human embryonic kidney cells. Mol. Cancer, 4:3.
11.
HochedlingerK., JaenischR.2002. Monoclonal mice generated by nuclear transfer from mature B and T donor cells. Nature, 415:1035–1038.
12.
LepikhovK., ZakhartchenkoV.et al.2008. Evidence for conserved DNA and histone H3 methylation reprogramming in mouse, bovine and rabbit zygotes. Epigenetics Chromatin, 1:8.
13.
LohY.-H., WuQ.et al.2006. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat. Genet., 38:431–439.
14.
MaheraliN., AhfeldtT.et al.2008. A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell, 3:340–345.
15.
McGrawS., VigneaultC.et al.2006. Characterization of linker histone H1FOO during bovine in vitro embryo development. Mol. Reprod. Dev., 73:692–699.
16.
MorganH.D., DeanW.et al.2004. Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming. J. Biol. Chem., 279,50:52353–52360.
NakamuraT., AraiY.et al.2007. PGC7/Stella protects against DNA demethylation in early embryogenesis. Nat. Cell Biol., 9:64–71.
19.
NakagawaM., KoyanagiM.et al.2008. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol., 26:101–106.
20.
OhsumiK., KatagiriC.1991. Characterization of the ooplasmic factor inducing decondensation of and protamine removal from toad sperm nuclei: involvement of nucleoplasmin. Dev. Biol., 148:295–305.
21.
OoiL., BelyaevN.D.et al.2006. BRG1 chromatin remodeling activity is required for efficient chromatin binding by repressor element 1-silencing transcription factor (REST) and facilitates REST-mediated repression. J. Biol. Chem., 281:38974–38980.
22.
PapanayotouC., MeyA.et al.2008. A mechanism regulating the onset of Sox2 expression in the embryonic neural plate. PLoS Biol., 6:e2.
23.
PayerB., Saitoum.et al.2003. Stella is a maternal effect gene required for normal early development in mice. Curr. Biol., 13:2110–2117.
24.
PeiL.2001. Identification of c-myc as a down-stream target for pituitary tumor-transforming gene. J. Biol. Chem., 276:8484–8491.
PhilpottA., LenoG.H.et al.1991. Sperm decondensation in Xenopus egg cytoplasm is mediated by nucleoplasmin. Cell, 65:569–578.
27.
ProbstA.V., SantosF.et al.2007. Structural differences in centromeric heterochromatin are spatially reconciled on fertilisation in the mouse zygote. Chromosoma, 116:403–415.
28.
QuivyJ.P., AlmouzniG.2003. Rad53: a controller ensuring the fine-tuning of histone levels. Cell, 115:508–510.
29.
RaiK., HugginsI.J.et al.2008. DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45. Cell, 135:1201–1212.
30.
ReikW., SantosF.et al.2003. Mammalian epigenomics: reprogramming the genome for development and therapy. Theriogenology, 59:21–32.
31.
RoddaD.J., ChewJ.L.et al.2005. Transcriptional regulation of nanog by OCT4 and SOX2. J. Biol. Chem., 280:24731–24737.
32.
SantosF., DeanW.2004. Epigenetic reprogramming during early development in mammals. Reproduction, 127:643–651.
33.
SantosF., PetersA.H.et al.2005. Dynamic chromatin modifications characterise the first cell cycle in mouse embryos. Dev. Biol., 280:225–236.
34.
SchierA.F.2007. The maternal-zygotic transition: death and birth of RNAs. Science, 316:406–407.
35.
ShahbazianM.D., GrunsteinM.2007. Functions of site-specific histone acetylation and deacetylation. Annu. Rev. Biochem., 76:75–100.
36.
ShawG., MorseS.et al.2002. Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J., 16:869–871.
37.
ShechterD., NicklayJ.J.et al.2009. Analysis of histones in Xenopus laevis: I. A distinct index of enriched variants and modifications exists in each cell type and is remodeled during developmental transitions. J. Biol. Chem., 284:1064–1074.
38.
SinghR.K., KabbajM.H.et al.2009. Histone levels are regulated by phosphorylation and ubiquitylation-dependent proteolysis. Nat. Cell Biol., 11:925–933.
39.
SridharanR., PlathK.2008. Illuminating the black box of reprogramming. Cell Stem Cell, 2:295–297.
40.
StanchevaI.2005. Caught in conspiracy: cooperation between DNA methylation and histone H3K9 methylation in the establishment and maintenance of heterochromatin. Biochem. Cell Biol., 83:385–395.
41.
StrasakL., BartovaE.et al.2009. H3K9 acetylation and radial chromatin positioning. J. Cell Physiol., 220:91–101.
42.
TakahashiK., YamanakaS.2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126:663–676.
43.
TakahashiK., TanabeK.et al.2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131:861–872.
TamadaH., ThuanN.V.et al.2006a. Chromatin decondensation and nuclear reprogramming by nucleoplasmin. Mol. Cell. Biol., 26:1259–1271.
46.
TamadaH., Van ThuanN.et al.2006b. Chromatin decondensation and nuclear reprogramming by nucleoplasmin. Mol. Cell. Biol., 26:1259–1271.
47.
TanakaM., KiharaM.et al.2005. H1FOO is coupled to the initiation of oocytic growth. Biol. Reprod., 72:135–142.
48.
TongY., TanY.et al.2007. Pituitary tumor transforming gene interacts with Sp1 to modulate G1/S cell phase transition. Oncogene, 26:5596–5605.
49.
TrounsonA.2005. Human embryonic stem cell derivation and directed differentiation. Ernst Schering Res. Found. Workshop, 54:27–44.
50.
TrounsonA.2006. The production and directed differentiation of human embryonic stem cells. Endocr. Rev., 27:208–219.
51.
UhlirovaR., HorakovaA.H.et al.2010. SUV39h- and A-type lamin-dependent telomere nuclear rearrangement. J. Cell. Biochem., 109:915–926.
52.
ValleeM., GravelC.et al.2005. Identification of novel and known oocyte-specific genes using complementary DNA subtraction and microarray analysis in three different species. Biol. Reprod., 73:63–71.
53.
ValleeM., RobertC.et al.2006. Cross-species hybridizations on a multi-species cDNA microarray to identify evolutionarily conserved genes expressed in oocytes. BMC Genomics, 7:113.
54.
VigneaultC., McGrawS.et al.2004. Transcription factor expression patterns in bovine in vitro-derived embryos prior to maternal–zygotic transition. Biol. Reprod., 70:1701–1709.
55.
WilmutI., SchniekeA.E.et al.1997. Viable offspring derived from fetal and adult mammalian cells. Nature, 385:810–813.
56.
YuJ., VodyanikM.A.et al.2007. Induced pluripotent stem cell lines derived from human somatic cells. Science, 318:1917–1920.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
